HBM Genomics
5
51M
3
0.62
1
0.40
- Areas of investment
Summary
Among the most successful fund investment fields, there are Biotechnology, Health Diagnostics. Among the most popular portfolio startups of the fund, we may highlight Xcell Biosciences. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
The usual cause for the fund is to invest in rounds with 2 partakers. Despite the HBM Genomics, startups are often financed by Nimble Ventures, Illumina Accelerator. The meaningful sponsors for the fund in investment in the same round are Viking Global Investors.
The top activity for fund was in 2017. The fund is constantly included in less than 2 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Investments analytics
Analytics
- Total investments
- 5
- Lead investments
- 1
- Rounds per year
- 0.62
- Follow on index
- 0.40
- Investments by industry
- Biotechnology (5)
- Health Diagnostics (4)
- Therapeutics (3)
- Robotics (2)
- Software (2) Show 4 more
- Investments by region
-
- United States (5)
- Peak activity year
- 2020
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Xcell Biosciences | 19 Jan 2022 | Biotechnology, Health Diagnostics, Manufacturing, Medical, Therapeutics | Early Stage Venture | 27M | United States, California, San Francisco |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.